Ellsworth Advisors’s Amgen AMGN Stock Holding History

Ellsworth Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$9.6M	Buy	22,754 +425	+2%	+$169K	1.55%	15
2026 Q2	$8M	Sell	22,329 -6,760	-23%	-$2.31M	1.31%	26
2026 Q1	$10.2M	Buy	29,089 +1,271	+5%	+$453K	1.92%	7
2025 Q4	$9.18M	Buy	27,818 +1,877	+7%	+$595K	1.81%	8
2025 Q3	$7.71M	Buy	25,941 +1,669	+7%	+$484K	1.65%	12
2025 Q2	$6.78M	Buy	24,272 +5,132	+27%	+$1.45M	1.65%	13
2025 Q1	$5.96M	Buy	+19,140	New	+$5.65M	1.56%	17
2021 Q4	–	Sell	-12,590	Closed	-$2.68M	–	147
2021 Q3	$2.68M	Buy	12,590 +2,318	+23%	+$534K	1.22%	32
2021 Q2	$2.5M	Buy	10,272 +1,429	+16%	+$352K	1.22%	29
2021 Q1	$2.2M	Buy	8,843 +819	+10%	+$195K	1.32%	22
2020 Q4	$1.84M	Buy	+8,024	New	+$1.85M	1.34%	22

Other funds holding AMGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Ellsworth Advisors's AMGN Position: Q3 2026 in Review

Ellsworth Advisors increased its Amgen (AMGN) stake by 1.9% in Q3 2026, buying an estimated $169K and bringing the position to 22,754 shares worth $9.6M. The position accounts for 1.55% of the portfolio, ranked #15.

Ellsworth Advisors first reported a position in AMGN in Q4 2020 and has held it in 11 quarters since. The position peaked at $10.2M in Q1 2026. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Ellsworth Advisors held 22,754 shares of Amgen worth $9.6M as of Q3 2026.
Ellsworth Advisors bought 425 Amgen shares in Q3 2026, an estimated $169K.
Amgen made up 1.55% of Ellsworth Advisors's portfolio in Q3 2026, its #15 holding.
Ellsworth Advisors first reported a position in Amgen in Q4 2020 and has held it in 11 quarters since.
Ellsworth Advisors's Amgen position peaked at $10.2M in Q1 2026.
2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Ellsworth Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.